| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_951ade9cb9f29eb8a29ddae1e2fc87e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5725daabf36b3e26b907b9604ca0ea8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8933b50cb95a6591169a881abaaccc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c31706c7e8f88f79f2558daeb775f414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d772b20886a6055cbe2f41ddfb96465d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_616d9946d86706ec802d382910678edc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3801bd3ea51f3ea70dc40d5991fef721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432ee3a2d4ec13ffc9eb92b028a12b75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8300c1cffd593a2bba49af79f417091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_371c1cbc1d944dc4b0c2bcc2d1f9bd88 |
| publicationDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150111644-A |
| titleOfInvention |
composition of preventing musclular damage by regulating micro environment |
| abstract |
The present invention provides a medical composition for preventing and treating human-like muscle destruction diseases containing losartan or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition of the present invention provides a medical composition for preventing and treating human and mammal-like muscle destruction diseases, which is characterized by inhibiting TGF-beta and reducing calcification in skeletal muscle to improve the microenvironment of stem cell transplantation. |
| priorityDate |
2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |